Trial Condition(s):

pregnancy, unplanned

Impact of SH T00658ID as compared to a monophasic contraceptive containing ethinylestradiol and levonorgestrel (SH D01155E) on hemostatic parameters

Bayer Identifier:

91477

ClinicalTrials.gov Identifier:

NCT00318799

EudraCT Number:

2005-004688-45

Study Completed

Trial Purpose

The aim of this study is to evaluate the impact of SH T00658ID (EV/DNG tablet) on hemostatic parameters in comparison to a reference oral contraceptive (OC) (SH D01155E) in a crossover design.

Inclusion Criteria
- Healthy female volunteers
Exclusion Criteria
- Pregnancy or lactation 
 - Any condition that might interfere with the outcome as all contraindications for OC use.

Trial Summary

Enrollment Goal
29
Trial Dates
black-arrow
Phase
2
Could I receive a placebo?
No
Products
Natazia/Qlaira (EV/DNG, BAY86-5027)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Dinox B.V.

Groningen, Netherlands, 9713GZ

Status
Completed
 

Trial Design